Clinical Trial Update: Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating ixazomib citrate with gemcitabine and doxorubicin for metastatic or unresectable urothelial carcinoma; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transitional Cell Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Ixazomib citrate (Ixazomib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING